Accel has 58 tracked deals to Maveron's 23. Stage focus, check size, and sector fit compared side by side. Verified investor data on StartupFundraising.com.
Accel is an active investor with 58 tracked deals. Maveron is an active investor with 23 tracked deals. Accel shows 35 more tracked rounds than Maveron in this dataset, which is the clearest signal of deployment pace between the two. Recent tracked names include Alyssum Therapeutics and Anysphere for Accel and Barkbus and Bend Health for Maveron.
Investors like Accel · Investors like Maveron · Accel co-investors · Full investor directory